Our pharmaceutical business, via Herbitec (M) Sdn. Bhd., represents a strategic foray into the healthcare sector, signalling the company’s vision for future growth and diversification. This new venture focuses on developing herbal-based treatment solutions that address prevalent health issues.

Herbitec (M) Sdn Bhd

In 2021, Tanco Holdings Berhad acquired a majority stake in Herbitec (M) Sdn. Bhd., a bioscience company, known for producing herbal preparations derived from botanical extracts. This acquisition underscores our commitment to embracing natural and herbal solutions in the healthcare industry. Herbitec’s expertise in botanical extracts is a key component in our strategy to develop innovative healthcare solutions.

Herbitec is a bioscience company producing herbal preparations derived from botanical extracts via proprietary extraction method of active compounds, also the ingredient formulation proprietor, product holder and register holder of trademarks and patent.

Innovative Products​

MAL Registration : MAL15070045TC


Noden is a complementary and alternative medicine that is traditionally used for fever and cold. We are undertaking clinical trials for Noden as a treatment for 4 strains of the dengue virus serotypes where it inhibits dengue virus replication. The effectiveness of Noden comes from a proprietary extraction method of active compounds, making it a potential novel solution in the fight against dengue fever. This product is part of our portfolio’s effort to address critical healthcare needs through innovative, plant-based therapies.

Commitment to Research and Development

Our pharmaceutical venture is not just about product development; it represents our dedication to investing in research and development. We are focused on creating clinically proven therapies, such as our patented anti-viral treatment for dengue fever, extracted from natural herbs. This approach positions us at the forefront of the healthcare industry’s evolution, as we strive to develop solutions that address some of the most pressing health concerns today.

Problem Statement

Dengue costs the world USD9billion annually.

Dengue fever virus (DENV) is a mosquito-borne RNA viral disease that is caused by a virus of the Flaviviridae family comprising of 4 serotypes. Based on a modelling estimates by WHO, there are up to 390 million dengue infections annually, 70% from Asia.

On-Going Study

Collaborating with Universiti Malaya to study the effects of Noden against dengue infection.

Interested parties may obtain a free dengue test at participating clinics if they suspect they have dengue.

Participating Clinic(s):

Klinik Sharani – Bangsar
No. 20 Jalan Bangsar Utama 1, Bangsar Utama, Kuala Lumpur, Wilayah Persekutuan

Klinik Sentosa – Ampang
No. 25, Jalan 11, Taman Putra, Ampang, Selangor

Other Products

MAL Registration : MAL21036112TC


Livarton is formulated to support liver health. It is traditionally used as a liver tonic that detoxifies the liver and aids in its rejuvenation. Livarton leverages on the power of natural herbs to protect against liver diseases and enhances the liver’s detoxification processes. It is important to note that Livarton is designed to support liver health and is not a substitute for conventional medical treatments. This herbal supplement is part of our commitment to offering natural health solutions that complement traditional medical approaches.

Competitive Advantages

  • Ease of treatment – in capsule form, orally-taken.
  • Formulated from natural herbs with vegan capsules.
  • Proprietary extraction method that maximizes bioactive compounds extraction from plants/herbs.
  • Our supplements are registered with the Malaysian Ministry of Health

Strategic Alliances

Engaging with Universiti Malaya on “Effect of NODEN supplement against dengue infection: a clinical trial study".

Status: Clinical Trial Study targeted to complete by 2024.

Enquiries - Herbitec

Fill out the form below, and we will be in touch shortly.